The intellectual property (IP) policy of MUG focuses on creating and disseminating knowledge and the optimization of benefits from the use of intellectual rights. The essential units at the University in the process of technology transfer and commercialization of intellectual property are the Technology Transfer Office (TTO) and the special purpose company of GUMed, Centre of Medical Innovations Ltd. (CMI Ltd.).
In 2017-2018, MUG had implemented the Innovation Incubator+ of the Ministry of Science and Higher Education. At present, the next edition of the programme is being carried out, entitled Innovation Incubator 2.0. Moreover, owing to work of TTC, MUG has applied to the programme of the European Institute of Innovation & Technology (EIT). As a consequence, since 2018 it has been a part of the EIT community within the area of health (EIT Health). Since that time, MUG, as a Regional Innovation Scheme (RIS), conducts works that are an integral part of the ‘2020 Horizon’ programme within scientific research and innovation. The EIT Health RIS Hub project includes the reinforcement of a local ecosystem and the development of an international cooperation network of the academic-business environment. EIT Health is a strong, diversified, and sustainable partnership, which includes leading organizations in education, research, technology, and innovation, at present including more than 140 partners from 14 European states. The maintenance of the MUG position as a developed centre Gdansk RIS Hub that is recognised in Poland and Europe will be a useful tool in developing interdisciplinary projects of commercial and implementation potential. In 2020, MUG will apply for the advancement in the community structures, to become an associate partner to gain access to the larger cooperation back-up from EIT, thus extending the support potential with additional programmes.